Compounds > alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol
Page last updated: 2024-09-02

alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol and deoxyglucose

alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol has been researched along with deoxyglucose in 1 studies

Compound Research Comparison

Studies
(alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol)		Trials
(alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol)		Recent Studies (post-2010)
(alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol)		Studies
(deoxyglucose)		Trials
(deoxyglucose)		Recent Studies (post-2010) (deoxyglucose)
901211,4261711,375

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
della Puppa, A; London, ED1

Other Studies

1 other study(ies) available for alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol and deoxyglucose

ArticleYear
Cerebral metabolic effects of sigma ligands in the rat.
    Brain research, 1989, Dec-29, Volume: 505, Issue:2

    Topics: Animals; Autoradiography; Blood Pressure; Brain; Carbazoles; Deoxyglucose; Heart Rate; Male; Pentazocine; Pyrimidines; Rats; Rats, Inbred F344; Receptors, Opioid; Receptors, sigma

1989